| Sodium butyrate induces DRP1-mediated mitochondrial fusion and apoptosis in human colorectal cancer cells D Tailor, ER Hahm, RK Kale, SV Singh, RP Singh Mitochondrion 16, 55-64, 2014 | 100 | 2014 |
| Guanylate-binding protein 1: an emerging target in inflammation and cancer AT Honkala, D Tailor, SV Malhotra Frontiers in immunology 10, 3139, 2020 | 86 | 2020 |
| Acacetin Inhibits In Vitro and In Vivo Angiogenesis and Downregulates Stat Signaling and VEGF Expression TA Bhat, D Nambiar, D Tailor, A Pal, R Agarwal, RP Singh Cancer Prevention Research 6 (10), 1128-1139, 2013 | 77 | 2013 |
| Inhibition of mitochondrial fusion is an early and critical event in breast cancer cell apoptosis by dietary chemopreventative benzyl isothiocyanate A Sehrawat, CS Croix, CJ Baty, S Watkins, D Tailor, RP Singh, SV Singh Mitochondrion 30, 67-77, 2016 | 43 | 2016 |
| Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer D Tailor, A Resendez, FJ Garcia-Marques, M Pandrala, CC Going, ... Cell Chemical Biology 28 (8), 1206-1220. e6, 2021 | 38 | 2021 |
| SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer MA Rice, V Kumar, D Tailor, FJ Garcia-Marques, EC Hsu, S Liu, ... Cell Reports Medicine 3 (2), 2022 | 25 | 2022 |
| Quantitative proteomic profiling reveals key pathways in the anticancer action of methoxychalcone derivatives in triple negative breast cancer CC Going, D Tailor, V Kumar, AM Birk, M Pandrala, MA Rice, T Stoyanova, ... Journal of proteome research 17 (10), 3574-3585, 2018 | 25 | 2018 |
| Synthesis and in vitro study of artemisinin/synthetic peroxide‐based hybrid compounds against SARS‐CoV‐2 and cancer L Herrmann, IA Yaremenko, A Çapcı, J Struwe, D Tailor, A Dheeraj, ... ChemMedChem 17 (9), e202200005, 2022 | 24 | 2022 |
| Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer D Tailor, CC Going, A Resendez, V Kumar, DK Nambiar, Y Li, A Dheeraj, ... British Journal of Cancer 124 (3), 604-615, 2021 | 19 | 2021 |
| Facile synthesis of C6‐substituted benz[4,5]imidazo[1,2‐a]quinoxaline derivatives and their anticancer evaluation R Singh, R Kumar, M Pandrala, P Kaur, S Gupta, D Tailor, SV Malhotra, ... Archiv der Pharmazie 354 (7), 2000393, 2021 | 12 | 2021 |
| Anticancer effects and associated molecular changes of Carica papaya against prostate cancer SP Singh, SV Mathan, A Dheeraj, D Tailor, RP Singh, A Acharya Cancer Research 79 (13_Supplement), 3004-3004, 2019 | 12 | 2019 |
| Reengineering ponatinib to minimize cardiovascular toxicity AP Hnatiuk, AAN Bruyneel, D Tailor, M Pandrala, A Dheeraj, W Li, ... Cancer research 82 (15), 2777-2791, 2022 | 11 | 2022 |
| Radiosensitization of head and neck squamous cell carcinoma (HNSCC) by a podophyllotoxin A Resendez, D Tailor, E Graves, SV Malhotra ACS Medicinal Chemistry Letters 10 (9), 1314-1321, 2019 | 9 | 2019 |
| Anticancer Attributes of silibinin: chemo-and radiosensitization of cancer A Dheeraj, D Tailor, SP Singh, RP Singh Role of nutraceuticals in cancer chemosensitization, 199-220, 2018 | 9 | 2018 |
| Impact of an immune modulator mycobacterium-w on adaptive natural killer cells and protection against COVID-19 SR Jaiswal, J Arunachalam, A Saifullah, R Lakhchaura, D Tailor, A Mehta, ... Frontiers in immunology 13, 887230, 2022 | 8 | 2022 |
| Acacetin inhibits In vitro and In vivo angiogenesis and downregulates STAT signaling and VEGF expression. Cancer Prev. Res. 2013; 6: 1128–1139. doi: 10.1158/1940-6207 TA Bhat, D Nambiar, D Tailor, A Pal, R Agarwal, RP Singh CAPR-13-0209.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 6 | |
| Butyric acid reverts DRP1-mediated cell proliferation and migration in colorectal cancer cells DM Tailor, ER Hahm, SV Singh, RP Singh Cancer Research 75 (15_Supplement), 1891-1891, 2015 | 4 | 2015 |
| Dietary and non-dietary phytochemicals in cancer control D Tailor, RP Singh Nutrition, Diet and Cancer, 585-622, 2012 | 2 | 2012 |
| Guanylate-binding protein 1 modulates proteasomal machinery in ovarian cancer D Tailor, FJ Garcia-Marques, A Bermudez, SJ Pitteri, SV Malhotra Iscience 26 (11), 2023 | 1 | 2023 |
| Pre-Clinical Investigation of a Novel Small Molecule Inhibitor Targeting YBX1 in AML TM Schnoeder, F Perner, AK Jayavelu, L Mao, Q Zhang, CJ Hsu, T Eifert, ... Blood 140 (Supplement 1), 491-492, 2022 | 1 | 2022 |
